Delivery Order SPE2DB25D3110-SPE2DB25FTDVT
Award Date 7/17/25
Potential Completion Date 7/18/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.81 firm fixed-price delivery order covers the supply of 4566878224 - DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to manage diabetes. The contract has an ultimate completion date of January 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,884.08 firm fixed-price delivery order is for the supply of 4566448537 DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,539.39, is a delivery order for the supply of 4567957850 DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication. The contract is not set aside and is a firm fixed-price agreement with an ultimate completion date of April 18, 2025. Additionally, AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, valued at $2,518.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order to supply 4566964347 DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,386.21 firm fixed price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication, with a completion date of July 8, 2025. The contract is not set aside and is part of Amerisourcebergen's broader $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,204.31 firm fixed-price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used for diabetes management. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,312.30 firm fixed-price delivery order is for the supply of 4567630969 DAPAGLIFLOZIN 10 MG TABLET 30S, a prescription medication. The award has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is a Delivery Order valued at $8,372.91 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of 4566904877 - DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product used for diabetes management. The contract has an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S. The $6,097.92 firm fixed-price contract has a completion date of March 18, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
- This federal contract award, valued at $62,107.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to supply DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a completion date of May 14, 2024. The contract has a Firm Fixed Price pricing type and was not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...